David Schwalb

Company: Pacira Biosciences

Job title: Director, Analytical Development, Cell & Gene Therapies

Seminars:

Panel Discussion: Potency Assay Development Over the Development Lifecycle 4:30 pm

• Should we start potency assay development early? Or should we wait until clearer signals emerge later in subsequent phases  that a therapy is likely to be safe and efficacious?  • How do we translate early phase potency assays into late phase assays?  • At what stage do you begin to qualify and validate? Read more

day: Conference Day One - PM